SLC4A3: A Drug Target and Potential Biomarker for Anion Exchange in the Human Body

Target Name: SLC4A3

NCBI ID: G6508

SLC4A3

SLC4A3: A Drug Target and Potential Biomarker for Anion Exchange in the Human Body

Sodium-glucose cotransporter 4A3 (SLC4A3) is a protein that is expressed in various tissues throughout the body. It is a member of the SLC family of transmembrane proteins, which are known for their ability to transport various substances across cell membranes. SLC4A3 is primarily expressed in the brain, where it is involved in the transport of neurons and glial cells.

SLC4A3 has also been shown to play a role in the regulation of anions, which are positively charged molecules that are involved in various physiological processes in the body. In particular, SLC4A3 is involved in the exchange of anions between the brain and the bloodstream. This protein has been shown to play a critical role in the regulation of the levels of anions in the brain, which is critical for maintaining the proper functioning of neurons and other cells.

One of the unique features of SLC4A3 is its ability to exchange anions with a wide variety of molecules. This protein has been shown to be involved in the exchange of anions with neurotransmitters, such as dopamine and glutamate, which are involved in the regulation of various physiological processes in the brain. Additionally, SLC4A3 has also been shown to be involved in the exchange of anions with ionizable molecules, such as calcium ions and magnesium ions, which are involved in the regulation of various physiological processes in the body.

SLC4A3 has also been shown to play a role in the regulation of the levels of anions in the brain, which is critical for maintaining the proper functioning of neurons and other cells. This protein has been shown to help regulate the levels of anions in the brain by controlling the movement of anions into and out of the cell. Additionally, SLC4A3 has been shown to play a critical role in the regulation of the levels of anions in the brain by controlling the activity of other genes that are involved in anion regulation.

SLC4A3 is also known as anion exchanger 3 (AE3), which is a protein that is involved in the regulation of anions in the body. This protein has been shown to play a critical role in the regulation of the levels of anions in the brain by controlling the movement of anions into and out of the cell. Additionally, SLC4A3 has been shown to play a key role in the regulation of the levels of anions in the brain by controlling the activity of other genes that are involved in anion regulation.

SLC4A3 has also been shown to be involved in the regulation of various physiological processes in the body. This protein has been shown to help regulate the levels of anions in the brain by controlling the movement of anions into and out of the cell. Additionally, SLC4A3 has been shown to play a critical role in the regulation of the levels of anions in the brain by controlling the activity of other genes that are involved in anion regulation.

In conclusion, SLC4A3 is a protein that is involved in the regulation of anions in the body. This protein has been shown to play a critical role in the regulation of the levels of anions in the brain by controlling the movement of anions into and out of the cell. Additionally, SLC4A3 has been shown to play a key role in the regulation of the levels of anions in the brain by controlling the activity of other genes that are involved in anion regulation. Given its involvement in the regulation of anions, SLC4A3 is a potential drug target and biomarker for various physiological processes in the body. Further research is needed to fully understand the role of SLC4A3 in anion regulation and its potential as a drug target and biomarker.

Protein Name: Solute Carrier Family 4 Member 3

Functions: Sodium-independent anion exchanger which mediates the electroneutral exchange of chloride for bicarbonate ions across the cell membrane

The "SLC4A3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC4A3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets